Latest Leverage News

Page 154 of 773
Reece Limited reported a 6% rise in sales revenue to $4.6 billion for the half-year ending December 2025, while profits declined amid challenging market conditions. The company continues to expand its branch network in Australia and the US, balancing growth ambitions with cost pressures.
Victor Sage
Victor Sage
23 Feb 2026
Citigroup Global Markets Australia has announced the record and ex-dividend dates for a fully franked dividend on MFG ordinary shares and its linked CitiFirst Self-Funding Instalment MINI, with dividends directed to reduce outstanding loan amounts.
Claire Turing
Claire Turing
20 Feb 2026
Mesoblast Limited is set to release its half-year financial results and operational update, spotlighting its FDA-approved cell therapy and expanding international partnerships.
Ada Torres
Ada Torres
20 Feb 2026
PolyNovo Limited reported a robust 25.2% increase in half-year revenue to A$75 million, driven by strong U.S. sales and product growth, despite a near break-even net profit impacted by a manufacturing slowdown and a fire at its R&D lab.
Ada Torres
Ada Torres
20 Feb 2026
Synertec Corporation has won operational technology contracts exceeding $1 million with Sydney Water, marking a significant step in its national expansion within Australia's water infrastructure sector.
Nora Hopper
Nora Hopper
20 Feb 2026
Advanced Innergy Holdings Ltd (ASX:AIH) has reported a robust FY25 performance highlighted by a successful IPO and strong growth across its core segments, setting a confident tone for FY26.
Victor Sage
Victor Sage
20 Feb 2026
FortifAI Limited has raised $5 million through a strategic placement led by a major Australian institutional fund manager, reinforcing its balance sheet and accelerating its AI development and commercialisation plans.
Sophie Babbage
Sophie Babbage
20 Feb 2026
SRJ Technologies has secured multiple new purchase orders for its BoltEx flange clamp technology from major international operators, reinforcing its growing global footprint and industry validation.
Maxwell Dee
Maxwell Dee
20 Feb 2026
Cambium Bio has secured FDA clearance to begin Phase 3 dosing for its lead ophthalmology product, Elate Ocular®, alongside key global partnerships and a $2.4 million capital injection from a major shareholder.
Ada Torres
Ada Torres
20 Feb 2026
Viking Mines has completed due diligence on its Nevada tungsten portfolio, confirming high-grade mineralisation and fast-tracking acquisition and exploration to meet urgent US supply needs.
Maxwell Dee
Maxwell Dee
20 Feb 2026
EV Resources has partnered with U.S.-based MineMaker LLC to accelerate its antimony projects in Mexico and Nevada, aiming to become a key supplier to North America’s critical minerals market.
Maxwell Dee
Maxwell Dee
20 Feb 2026
Inghams Group reports flat revenue but a sharp 42% drop in EBITDA for the first half of FY26, revising full-year earnings guidance lower amid ongoing cost inflation and operational challenges.
Victor Sage
Victor Sage
20 Feb 2026